1. Home
  2. SHEN vs ORIC Comparison

SHEN vs ORIC Comparison

Compare SHEN & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$15.97

Market Cap

880.2M

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$8.16

Market Cap

837.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
ORIC
Founded
1902
2014
Country
United States
United States
Employees
1041
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.2M
837.3M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
SHEN
ORIC
Price
$15.97
$8.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
13
Target Price
$26.00
$19.73
AVG Volume (30 Days)
358.5K
1.3M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
19.67
EPS
N/A
N/A
Revenue
$357,854,000.00
N/A
Revenue This Year
$7.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.08
N/A
52 Week Low
$9.67
$4.65
52 Week High
$17.35
$14.93

Technical Indicators

Market Signals
Indicator
SHEN
ORIC
Relative Strength Index (RSI) 52.49 31.58
Support Level $12.66 $7.90
Resistance Level $17.13 $13.89
Average True Range (ATR) 0.96 0.50
MACD -0.08 -0.10
Stochastic Oscillator 76.18 4.87

Price Performance

Historical Comparison
SHEN
ORIC

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: